Familial chylomicronemia due to a circulating inhibitor of lipoprotein lipase activity.
A mother and her son who have lipoprotein phenotype I are described. They differed from subjects with lipoprotein lipase deficiency in that lipoprotein lipase was present in adipose tissue respectively at 30- and 2-fold the levels seen in normal subjects, and from subjects with apoprotein C-II deficiency in that apoprotein C-II was present in their plasma. They appeared to have an inhibitor to lipoprotein lipase activity in their whole plasma that inhibited that activity eluted from adipose tissue with heparin and that activity present in postheparin plasma of normals. The inhibitor was non-dialyzable, heat-stable, sensitive to repeated freezing and thawing, and appeared to be present in the non-lipoprotein fraction of plasma. The presence of chylomicronemia and the plasma inhibitor in the mother and her son, and possibly in her father and grandson, argues against this being inherited as an autosomal recessive abnormality, as are lipoprotein lipase deficiency and apoprotein C-II deficiency.
D000273:Adipose Tissue / Q000201:enzymology; D000328:Adult; D001053:Apolipoproteins / Q000097:blood; D002914:Chylomicrons / Q000097:blood*; D005260:Female; D005749:Gastric Inhibitory Polypeptide / Q000097:blood; D006493:Heparin; D006801:Humans; D008072:Hyperlipoproteinemia Type I / Q000235:genetics* / Q000378:metabolism; D006951:Hyperlipoproteinemias / Q000235:genetics*; D008066:Lipolysis; D008071:Lipoprotein Lipase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010375:Pedigree
D001053:Apolipoproteins; D002914:Chylomicrons; D005749:Gastric Inhibitory Polypeptide; D006493:Heparin; D008071:Lipoprotein Lipase